Related Experiment Videos
Ruptured appendicitis in children: continuing controversy over antibiotic combinations
Insights
Penicillin/streptomycin/sulfadiazine (P/S/S) antibiotics showed fewer infection complications in ruptured appendicitis cases compared to cephalothin/cephalexin (C/C). This prospective study suggests P/S/S may be a more effective antibiotic choice for pediatric appendicitis.
Area of Science:
- Pediatric Surgery
- Infectious Diseases
- Pharmacology
Background:
- Appendicitis is a common surgical emergency in children.
- Ruptured appendicitis increases the risk of infectious complications.
- Antibiotic selection is crucial in managing complicated appendicitis.
Purpose of the Study:
- To compare the efficacy of two antibiotic regimens in children with ruptured appendicitis.
- To evaluate the incidence of infectious complications associated with different antibiotic treatments.
- To assess the safety and adverse reactions of the antibiotic regimens used.
Main Methods:
- A prospective study involving 36 children diagnosed with ruptured appendicitis.
- Patients were randomly assigned to two treatment groups.
- Group 1 received penicillin/streptomycin/sulfadiazine (P/S/S).
- Group 2 received cephalothin and cephalexin (C/C).
Main Results:
- No major infectious complications were observed in the P/S/S group.
- Four major infectious complications occurred in the C/C group.
- No serious adverse reactions to either antibiotic regimen were reported in either group.
Conclusions:
- The combination of penicillin/streptomycin/sulfadiazine appears to be associated with a lower rate of infectious complications in pediatric ruptured appendicitis compared to cephalothin/cephalexin.
- Both antibiotic regimens were well-tolerated with no serious adverse events.
- Further research may be warranted to confirm these findings and optimize antibiotic therapy for ruptured appendicitis.
Abstract:
A prospective study has been made of 36 children with ruptured appendicitis. Alternate patients were managed with a standard protocol of therapy differing only in the antibiotics used. One group received a combination of penicillin/streptomycin/sulfadiazine while the other children were treated with cephalothin (Keflin) and cephalexin (Keflex). No major infections complications occurred in the P/S/S study group but there were four in the C/C patients. No serious adverse reactions due to the antibiotics occurred in either group.